Get started
Author

F. Erdkamp

Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial
2017 · Daniel P Petrylak, Ronald de Wit, et al. · The Lancet · 172
PDF
Randomized phase III study of capecitabine, oxaliplatin, and bevacizumab with or without cetuximab in advanced colorectal cancer (ACC), the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG)
2008 · C. J. Punt, J. Tol, et al. · Journal of Clinical Oncology · 129
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial
2019 · Daniel P Petrylak, Ronald de Wit, et al. · The Lancet Oncology · 87
Abstract S1-03: First results from the multicenter phase III DATA study comparing 3 versus 6 years of anastrozole after 2-3 years of tamoxifen in postmenopausal women with hormone receptor-positive early breast cancer
2017 · VC Tjan-Heijnen, IE Van Hellemond, et al. · Cancer Research · 30
Sclerosing peritonitis: an unusual cause of ascites in a patient with systemic lupus erythematosus.
2006 · M J A E Pepels, F P J Peters, et al. · PubMed · 30
Randomized study comparing efficacy/toxicity of monotherapy trastuzumab followed by monotherapy docetaxel at progression, and combination trastuzumab/docetaxel as first-line chemotherapy in HER2-neu positive, metastatic breast cancer (MBC) (HERTAX study)
2008 · M. Bontenbal, C. Seynaeve, et al. · Journal of Clinical Oncology · 19
Sequential compared to combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (ACC): A Dutch Colorectal Cancer Group (DCCG) phase III study
2007 · C. J. Punt, M. Koopman, et al. · Journal of Clinical Oncology · 11
Cyclophosphamide, epirubicin and cisplatin (CEP) versus epirubicin plus cisplatin (EP) in stage Ic-IV ovarian cancer: a randomized phase III trial of the Gynecologic Oncology Group of the Comprehensive Cancer Center Limburg
1999 · J Wils, H van Geuns, et al. · Anti-Cancer Drugs · 8
3000 ORAL Randomised phase III study of capecitabine, oxaliplatin and bevacizumab (CAPOX-B) with or without cetuximab in advanced colorectal cancer (ACC), the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim safety analysis
2007 · J. Tol, M. Koopman, et al. · European Journal of Cancer Supplements · 5
Lipsome-encapsulated doxorubicin (MYOCET) and cyclophosphamide is superior to epirubicin and cyclophosphamide in first-line therapy of metastatic breast cancer
2001 · S. Chan, N. Davidson, et al. · European Journal of Cancer · 5
Phase III study of liposome-encapsulated doxorubicin (TLC D-99) and cyclophosphamide (CPA) vs. epirubicin (EPI) and CPA in first-line treatment of metastatic breast cancer (MBC)
1999 · S. Chan, N. Davidson, et al. · European Journal of Cancer · 5
Unusual presentation of Hodgkin’s lymphoma
2002 · C.T.A.M. Knibbeler-van Rossum, F.J.P. Peters, et al. · Annals of Oncology · 3
Toxic dermatitis in patients treated with Taxotere® (docetaxel): three case reports
2011 · B. van Oijen, M. Pleunis, et al. · International Journal of Clinical Pharmacology and Therapeutics · 2
Adding the specific COX-2 inhibitor celecoxib to docetaxel plus carboplatin in first line for stage IC-IV epithelial ovarian cancer: A randomized phase II study
2009 · A. Reyners, W. M. Smit, et al. · Journal of Clinical Oncology · 2
An uncommon cause of anaemia in ulcerative colitis
1995 · J VANESSER, L BOS, et al. · The Netherlands Journal of Medicine · 2
168 A phase II study of docetaxel, epirubicin, and cispiatin with G-CSF (ienograstim) support in patients with advanced ovarian cancer
2003 · R. Lalisang, F. Erdkamp, et al. · European Journal of Cancer Supplements · 1
12. Treatment of intermediate and high-grade non-Hodgkin's lymphoma in the elderly
1997 · F PETERS, R LALISANG, et al. · The Netherlands Journal of Medicine · 1
Abscess of the spleen
1996 · F PETERS, M HOCHSTENBAG, et al. · The Netherlands Journal of Medicine · 1
PP-7-6 Dose dense epirubicin (E) and paclitaxel (P) with G-CSF in metastatic breast cancer (MBC)
1996 · J. Nortier, J. Wils, et al. · European Journal of Cancer · 1
PD04-02: Recovery of Ovarian Function in Breast Cancer Patients with Chemotherapy-Induced Amenorrhea Receiving Anastrozole in the Dutch DATA Study.
2011 · VC Tjan-Heijnen, CH Smorenburg, et al. · Cancer Research
Therapeutic management of metastatic breast cancer across Europe: European observatory and survey (EOS).
2011 · K. Krzemieniecki, S. Antolín Novoa, et al. · Journal of Clinical Oncology
Treatment of follicular non-Hodgkin lymphoma
1997 · H. Bron, F. Erdkamp
Works count: 22
Citation count: 514
H-index: 8
I10-index: 7
Year
Topic
Type